Bibliometric Analysis of Health-related Quality of Life Assessment Instruments for Chronic Hepatitis Patients
1.School of Medicine and Health Management,Guizhou Medical University,Guiyang 550004,China
2.Guizhou Provincial People 's Hospital,Guiyang 550002,China
*Corresponding author:WU Hongyan,Professor,Master supervisor;E-mail:why376570155@126.com
RAN Xuerong,ZHANG Tangqin,CAI Yifan, et al. Bibliometric Analysis of Health-related Quality of Life Assessment Instruments for Chronic Hepatitis Patients [J]. Chinese General Practice, 2018, 21(35): 4377-4382. DOI: 10.12114/j.issn.1007-9572.2018.00.105.
冉雪蓉,张堂钦,蔡一凡等. 基于文献计量法分析健康相关生命质量量表在慢性肝炎领域中的应用[J]. 中国全科医学, 2018, 21(35): 4377-4382. DOI: 10.12114/j.issn.1007-9572.2018.00.105.
[1]梅长林,李兆申,朱樑.内科手册[M].7版.北京:人民卫生出版社,2011:155-156.
MEI C L,LI Z S,ZHU L.Internal medicine manual[M].7th ed.Beijing:People's Medical Publishing House,2011:155-156.
[2]拉米夫定临床应用专家组,万谟彬.2004年拉米夫定临床应用专家共识[J].中华肝脏病杂志,2004,12(7):425-428.
Lamivudine Clinical Application Expert Group,WAN M B.Expert consensus of lamivudine clinical application 2004[J].Chinese Journal of Hepatology,2004,12(7):425-428.
[3]WANG F S,FAN J G,ZHANG Z,et al.The global burden of liver disease:the major impact of China[J].Hepatology,2014,60(6):2099-2108.DOI:10.1002/hep.27406.
[4]崔妹娟.丙型肝炎病毒感染危险因素的病例对照研究[D].北京:中国疾病预防控制中心,2014.
CUI M J.Risk factors for hepatitis C virus infection:a case-control study[D].Beijing:Chinese Center for Disease Control and Prevention,2014.
[5]江山.酒精性肝硬化和乙肝肝硬化患者血清代谢组学初步研究[D].杭州:浙江大学,2011.
JIANG S.Preliminary study on serum metabonomics in patients with alcoholic liver cirrhosis and hepatitis B cirrhosis[D].Hangzhou:Zhejiang University,2011.
[6]许嘉,巴蕾,吴文仓,等.脂肪肝的流行病学研究进展[J].慢性病学杂志,2013,14(7):539-542.
XU J,BA L,WU W C,et al.Epidemiological studies progress of fatty liver[J].Chronic Pathemathol Journal,2013,14(7):539-542.
[7]李云云,许卫国,朱立国,等.慢性乙肝患者生命质量及影响因素分析[J].中国公共卫生,2013,29(11):1574-1576.DOI:10.11847/zgggws2013-29-11-05.
LI Y Y,XU W G,ZHU L G,et al.Quality of life and its influencing factors among chronic hepatitis B patients[J].Chinese Journal of Public Health,2013,29(11):1574-1576.DOI:10.11847/zgggws2013-29-11-05.
[8]王超秀.慢性肝炎患者生命质量测定量表的研制与考评[D].昆明:昆明医学院,2011.
[9]中华医学会传染病与寄生虫病学分会,中华医学会肝病学分会.病毒性肝炎防治方案[J].中华内科杂志,2000,19(1):56-62.
Branch of Infectious Diseases and Parasitology,Branch of Hepatology,Chinese Medical Association.Prevention and treatment programs of viral hepatitis[J].Chinese Journal of Internal Medicine,2000,19(1):56-62.
[10]崔伟红,范桂玲,胡茂红,等.SF-36量表用于慢性乙型肝炎生命质量测定的效果评价[J].医学与哲学,2007,28(9):31-33.
CUI W H,FAN G L,HU M H,et al.The effect evaluation on measuring quality of life in chronic hepatitis B patients by SF-36 scale[J].Medicine and Philosophy,2007,28(9):31-33.
[11]疾病预防控制局.2016年全国法定传染病疫情概况[EB/OL].(2017-02-23)[2017-10-15].http://www.nhfpc.gov.cn/jkj/s3578/201702/38ca5990f8a54ddf9ca6308fec406157.shtml.
[12]李广峰.大黄的药理作用及临床应用分析[J].中国医药指南,2013,11(16):317-318.
LI G F.Pharmacological effects and clinical application analysis of rhubarb [J].Chinese Medicine Guide,2013,11(16):317-318.
[13]傅英兰,窦乐功,尤龙.慢性乙型肝炎的抗病毒治疗进展[J].山东医药,2002,42(13):60-61.
FU Y L,DOU L G,YOU L.Advances in antiviral therapy of chronic hepatitis B[J].Shandong Medical Journal,2002,42(13):60-61.
[14]谢莹.慢性肝病患者内在力量、自我效能与生命质量的相关性研究[D].延边:延边大学,2016.
[15]高国福,郭欣,张颖,等.生存质量研究概述[J].实用预防医学,2000,25(6):479-481.
GAO G F,GUO X,ZHANG Y,et al.Quality of life research overview[J].Practical Preventive Medicine,2000,25(6):479-481.
[16]伍红艳,田彩林.2009—2013年国内药物经济学评价类文献之质量分析[J].中国药房,2015,26(11):1441-1445.DOI:10.6039/j.issn.1001-0408.2015.11.01.
WU H Y,TIAN C L.Quality analysis of pharmacoeconomics evaluation and application literature in China during 2009—2013[J].China Pharmacy,2015,26(11):1441-1445.DOI:10.6039/j.issn.1001-0408.2015.11.01.
[17]伍红艳.健康效用值测量研究[D].沈阳:沈阳药科大学,2012.
[18]张利霞,李星丹,郑蔚,等.慢性肝病患者的生存质量量表应用现状[J].中国实用神经疾病杂志,2012,15(2):8-10.
ZHANG L X,LI X D,ZHENG W,et al.Application status of quality of life scale in patients with chronic liver disease[J].Chinese Journal of Practical Nervous Diseases,2012,15(2):8-10.
[19]WARE J E,SNOW K K,KONINSKI M.SF-36 health survey:manual and interpretation guide[M].Boston,MA:New England Medical Center,1993.
[20]WHOQOL Group.Development of the World Health Organization WHOQOL-BREE quality of life assessment[J].Psycho Med,1998,28:551-558.
[21]李凌江,郝伟,杨德森,等.社区人群生活质量研究─Ⅲ生活质量问卷(QOLI)的编制[J].中国心理卫生杂志,1995,9(5):227-231.
LI L J,HAO W,YANG D S,et al.Quality of life of community population— establishment of Quality of Life Questionnaire(QOLI)[J].Chinese Mental Health Journal,1995,9(5):227-231.
[22]肖水源.《社会支持评定量表》的理论基础与研究应用[J].临床精神医学杂志,1994,4(2):98-100.
XIAO S Y.The theoretical foundation and research application of Social Support Rating Scale[J].Journal of Clinical Psychiatry,1994,4(2):98-100.
[23]WHOQOL Group.The World Health Organization Quality of Life assessment(WHOQOL):development and general psychometric properties[J].Soc Sci Med,1998,46(12):1569-1585.
[24]黄津芳,刘玉莹.护理健康教育学[M].北京:科学技术出版社,2002:60.
[25]ZHAN L.Quality of life:conceptual and measurement issues[J].J Adv Nurse,1992,17(7):795-800.
[26]YOUNOSSI Z M,GUYATT G,KIWI M,et al.Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease[J].Gut,1999,45(2):295-300.
[27]FEIFEL H,STRACK S,NAGY V T.Coping strategies and associated features of medically ill patients[J].Psychosom Med,1987,49(6):616-625.
[28]王妍,王俐琼,张玮,等.中医QOL量表(测试版)对于慢性乙型肝炎湿热中阻证患者应用评价研究[J].中西医结合肝病杂志,2016,26(1):23-25.DOI:103969/ j.issn.1005-0264.2016.01.009.
WANG Y,WANG L Q,ZHANG W,et al.The application of QOL Scale(test version) to the patients with chronic hepatitis B dampness and heat resistance[J].Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases,2016,26(1):23-25.DOI:103969/j.issn.1005-0264.2016.01.009.
[29]林彦.肝炎后肝硬化患者生存质量与中医证候的相关性研究[D].上海:上海中医药大学,2008.
LIN Y.Study on the correlation between survival quality and TCM syndrome in patients with post-hepatitis cirrhosis[D].Shanghai:Shanghai University of Traditional Chinese Medicine,2008.
[30]陈非凡.中医肝病PRO量表的研制与考核[D].广州:广州中医药大学,2007.
CHEN F F.Development and assessment of PRO Scale of liver disease in TCM[D].Guangzhou:Guangzhou University of Chinese Medicine,2007.
[31]万崇华,李晓梅,杨铮,等.慢性病患者生命质量测定与应用[M].北京:科学出版社,2015:62-65,186-199.
[32]王凤云,唐旭东,张引强,等.影响慢性乙型肝炎患者生存质量因素调查与分析[J].胃肠病学和肝病学杂志,2010,19(5):404-407.
WANG F Y,TANG X D,ZHANG Y Q,et al.Investigation and analysis of factors for the quality of life in patients with chronic hepatitis B[J].Chinese Journal of Gastroenterology and Hepatology,2010,19(5):404-407.
[33]汪向东.心理卫生评定量表手册[M].北京:中国心理卫生杂志社,1993:160-161.
WANG X D.Mental health rating scale manual[M].Beijing:Chinese Mental Health Journal,1993:160-161.
[34]DEROGATIS L R,RICKELS K,ROCK A F.The SCL-90 and the MMPI:a step in the validation of a new self-report scale[J].Br J Psychiatry,1976,128(3):280-289.
[35]张明园.精神科评定量表手册[M].长沙:湖南科技出版社,1993:122-127.
ZHANG M Y.Psychiatric rating scale manual[M].Changsha:Hunan Science and Technology Press,1993:122-127.
[36]SEHWARZER R,ARISTI B.Optimistic self beliefs:assessment of general perceived self efficacy in thirteen cultures[J].Word Psychology,1997,3(1/2):177-190.
[37]FOLKMAN S,LAZARUS R S,GRUEN R J.Appraisal,coping,health status,and psychological symptoms[J].J Pers Soc Psychol,1986,50(3):571-579.
[38]李跃平,黄子杰,张宏,等.SF-36量表在乙型肝炎患者生存质量测量中的可行性评价[J].中国预防医学杂志,2007,8(4):352-355.
LI Y P,HUANG Z J,ZHANG H,et al.Feasibility of the MOS 36-item short health survey in the assessment of life in hepatitis B patients[J].Chinese Prevention Medicine,2007,8(4):352-355.